-
NMPA Issued the Administrative Measures for Key Laboratories of NMPA
2020-01-06
NMPA has organized the formulation of and released on January 6,2020 the Administrative Measures for Key Laboratories of NMPA.
-
NMPA Issued the Announcement on the Guidelines for Real-World Evidence to Support Drug Development and Review (Interim)
2020-01-07
NMPA has organized the formulation of the Guidelines for Real-World Evidence to Support Drug Development and Review (Interim).
-
NMPA Released Announcement on the Application of 15 ICH Guidelines Including E1: Extent of Population Exposure to Assess Clinical Safety: For Drugs Intended for Long-term Treatment of Non-Life-Threatening Conditions
2019-11-12
On November 12, 2019, NMPA issued the Announcement on the Application of 15 ICH Guidelines Including E1: Extent of Population Exposure to Assess Clinical Safety: For Drugs Intended for Longterm Treatment of Non-Life-Threatening Conditions.
-
NMPA Released Announcement on the Application of 13 ICH Guidelines Including S1A: Guideline on the Need for Carcinogenicity Studies of Pharmaceuticals
2019-11-12
On November 12, 2019, NMPA issued the Announcement on the Application of 13 ICH Guidelines Including S1A: Guideline on the Need for Carcinogenicity Studies of Pharmaceuticals.
